Explore our top-rated medical systems and high-precision instruments engineered for orthopedic surgery, trauma care, and clinical workflows.
As a recognized global leader in orthopedic device manufacturing, our facility integrates high-precision Swiss-type 9-axis CNC machining, automated surface treatment, and stringent metallurgical verification. We specialize in Proximal Femoral Nail Antirotation (PFNA) systems designed to solve the biomechanical challenges of trochanteric femoral fractures.
Every PFNA nail and helical blade is manufactured using biocompatible Titanium Alloy (Ti-6Al-4V ELI per ASTM F1472 / ISO 5832-3) or Pure Titanium (ASTM F67). Tensile strengths exceed 930 MPa, offering superior yield strength and resistance to fatigue under cyclic physiological loading.
Operating under robust ISO 13485 and ISO 9001 quality frameworks, our implants meet regulatory standards for global entry. Technical documentation (STED format), clinical evaluation reports, and full material lot traceability empower international distributors with streamlined market registration.
Implants can be delivered pre-sterilized in double-peel blister packaging processed via Co-60 gamma radiation, achieving a Sterility Assurance Level (SAL) of 10⁻⁶. This eliminates hospital reprocessing overhead, reduces OR preparation time, and mitigates surgical site infection risks.
Precision specifications of our Proximal Femoral Intramedullary Nailing System engineered for osteoporotic and high-energy trochanteric fracture management.
| System Parameter | Technical Specification | Clinical & Mechanical Benefit |
|---|---|---|
| Raw Material Specification | Ti-6Al-4V ELI (ASTM F1472 / ISO 5832-3) / Pure Titanium Grade 3 (ASTM F67) | High fatigue limit (>510 MPa at 10⁷ cycles), biomechanical elasticity matching natural bone. |
| Proximal Angle / M-L Angle | 5° Mediolateral angle for trochanteric insertion | Minimizes soft tissue trauma at the insertion point; allows easy entry through the tip of the greater trochanter. |
| Helical Blade Design | Single-step compacting helical geometry with anti-rotation lock | Achieves cancellous bone compaction rather than tissue removal; drastically reduces cut-out rate in osteoporotic bone. |
| Distal Locking Options | Dynamic & Static dual locking slots (Ø 4.9 mm screws) | Allows controlled secondary fracture compression while preventing rotational displacement. |
| Surface Treatment | Type II Anodization & Micro-arc Oxidation (MAO) | Enhances surface hardness, reduces wear debris formation, and improves fatigue resistance under physiological loads. |
| Sterilization Assurance | Co-60 Gamma Irradiation (SAL 10⁻⁶) per ISO 11137 | Ensures immediate surgical readiness, long shelf-life integrity (5 years), and zero hospital autoclave costs. |
Trochanteric femoral fractures (AO/OTA 31-A1, 31-A2, and 31-A3) represent a significant portion of trauma admissions worldwide, particularly among elderly populations affected by osteoporosis. Traditional fixation constructs, such as the Dynamic Hip Screw (DHS) or standard two-screw intramedullary nails, rely heavily on thread-cutting lag screws. In compromised cancellous bone, traditional lag screws can compromise bone stock during insertion, elevating the incidence of implant cut-out, rotation failure, and Varus collapse.
Clinical Information Gain: Comparative biomechanical studies confirm that compaction-based helical blades increase rotational stability by over 48% compared to standard thread-cutting lag screws. The compacting action creates a dense structural envelope of bone around the blade, significantly increasing resistance to Tip-Apex Distance (TAD) related failures.
The core innovation of the PFNA system lies in its helical blade mechanism. During insertion, the blade does not cut away the delicate cancellous matrix of the femoral head; instead, it radially compacts the surrounding bone trabeculae. This compaction mechanism increases the density of the bone-implant interface, providing firm mechanical anchorage even in severely osteoporotic bone stock (DEXA T-score < -2.5).
Rotational instability is a primary contributor to early fixation failure in unstable intertrochanteric fractures (AO/OTA 31-A2/A3). The wide surface area of the PFNA helical blade distributes load evenly across the femoral head. When combined with an integrated internal locking mechanism, the blade locks rigid with the intramedullary nail, forming a load-bearing frame that suppresses rotational torque and lateral sliding.
Proper surgical technique requires positioning the tip of the load-bearing element within 20 mm of total TAD on AP and lateral fluoroscopic views. The anatomical curvature of our PFNA intramedullary nail—offered in standard 180 mm, 240 mm, and long reamed/unreamed variants (280–420 mm)—aligns with the natural anterior bow of the femur, preventing anterior cortical impingement and perforation during nail insertion.
As hospital procurement boards and international distributors evaluate medical device partnerships, the global orthopedic market is undergoing structural shifts toward efficiency, customization, and supply chain resilience.
Global healthcare systems are moving away from non-sterile bulk shipments that burden hospital central sterile services departments (CSSD). Pre-sterilized PFNA single-use packs drastically lower hospital operating costs, mitigate cross-contamination risks, and enable simplified inventory tracking via UDI (Unique Device Identification) barcoding.
Leading distributors increasingly request tailor-made instrument sets, laser-engraved branding, and customized tray ergonomics. Our OEM manufacturing center delivers end-to-end support—from initial 3D CAD modeling and prototype validation to regulatory file assembly—shortening product launch cycles for private-label brands.
Minimally Invasive Surgery (MIS) demands radiolucent carbon-fiber carbon targeting arms that offer complete radiolucency under C-arm imaging. Our next-generation surgical instrument kits reduce fluoroscopic exposure times for OR staff while delivering high alignment accuracy during distal locking screw placement.
Detailed technical answers to common questions asked by hospital procurement departments, orthopedic device importers, and OEM brand owners.
All PFNA products are backed by ISO 13485 and ISO 9001 quality management system documentation, CE compliance files, and full raw material chemical/mechanical test certificates (Mill Test Reports per ASTM F1472 for Ti-6Al-4V ELI). Every production batch undergoes rigorous dimensional verification, surface roughness analysis, and fatigue testing prior to release.
Yes. We offer comprehensive OEM/ODM manufacturing services, including custom laser marking (UDI barcodes, part numbers, lot codes, custom logos), specialized color anodizing for implant size coding, custom instrument tray design, and private-label box packaging tailored to meet target market regulatory guidelines.
Standard catalog items maintain a baseline inventory for rapid dispatch within 7 to 14 business days. For customized OEM/ODM projects requiring new tooling, specialized tray fabrication, or custom sterile packaging validation, typical production turnaround ranges from 30 to 45 days following engineering drawing sign-off.
Our sterile packaging operations are conducted inside ISO Class 7 cleanrooms using medical-grade Tyvek blister packaging. The sterilization process is executed using Cobalt-60 (Co-60) gamma irradiation verified under ISO 11137 standards to achieve a validated Sterility Assurance Level (SAL) of 10⁻⁶ with a 5-year shelf-life stability.
Yes. We provide complete clinical documentation, including step-by-step surgical technique manuals, fluoroscopic positioning guides, instrument sterilization protocols, and video tutorials. Additionally, we assist global distributors by conducting online technical training webinars and supporting hands-on cadaver/sawbones workshops.